CBC sells on CBD's coat-tails, and on paper the ride looks earned. The two share one molecular formula, C21H30O2, arranged as two different structural isomers; both are non-intoxicating; and the plant builds both from CBGA. The resemblance ends at the evidence. CBD is the active ingredient in an approved prescription medicine and has been studied far more, while CBC's effects in people remain largely uncharacterised.
4 sections · At a glance · What the evidence supports · Common questions · …
Run CBD and THC through a formula check and they come out as twins: both are C21H30O2. Run them through a person and they part company. THC gets people high. CBD doesn't; it is non-intoxicating. The two are structural isomers, the same atoms arranged differently, and that small change in shape is enough to split them on effects, on legal status and on drug-test risk.
4 sections · At a glance · What's actually established · Common questions · …
Put a bottle of CBDV beside a bottle of CBD and the two can read like siblings. As molecules, they are: CBDV (cannabidivarin) shares the core structure of CBD (cannabidiol), with a three-carbon side chain where CBD's is longer, which makes it CBD's propyl analog, and neither one is intoxicating. They part company in the research. CBD has been studied extensively in people, while most of CBDV's effects are unestablished, and the wellness benefits marketed for either one are not established.
4 sections · Side by side · What the evidence establishes · Common questions · …
On a chemistry slide, CBDV and THCV look like twins: both three-carbon "varin" cannabinoids, both C₁₉H₂₆O₂. Open the research record and the likeness falls apart. CBDV is non-intoxicating; what THCV does to the head shifts with dose. CBDV went through a proper clinical trial and missed its primary endpoint. THCV's best-known claim, appetite suppression, has no primary evidence in people.
4 sections · Side by side · The settled facts · Common questions · …
CBG (cannabigerol) and CBC (cannabichromene) are siblings. Both come from CBGA, both are non-intoxicating, and on a shelf of calm-and-comfort products they can pass for interchangeable. CBG is simply the neutral form of that shared "mother" precursor, while CBC sits on a separate major branch the plant reaches through CBCA. Where they part company is the evidence, and the gap is wide: our registry holds one small human trial for CBG and essentially none for CBC.
3 sections · Side by side · What the evidence settles · Common questions
On a hemp-shop shelf the two bottles look like siblings: CBD, the ingredient that built the category, and CBG, sold as the next thing. On the evidence they are distant relatives. CBD (cannabidiol) is the most-studied minor cannabinoid and the active ingredient in an FDA-approved epilepsy medicine. CBG (cannabigerol) has a single small human trial in our registry.
3 sections · At a glance · What's actually established · Common questions
Walk the gummy aisle and the pairing writes itself: CBG for the day, CBN for the night. The chemistry puts them at opposite ends of the plant's life. CBG (cannabigerol) is the "mother" cannabinoid, the neutral form of CBGA. CBN (cannabinol) is what THC oxidises into as cannabis ages, and it sells widely as a sleep aid, a use the evidence has not established. Neither is meaningfully intoxicating: CBG not at all, CBN mildly at most.
3 sections · At a glance · What's actually established · Common questions
Put CBG and THC on the same receptor and they pull in opposite directions. THC (tetrahydrocannabinol) switches CB₁ on as a partial agonist, and that is where the cannabis high comes from; in lab studies CBG (cannabigerol) blocks the same receptor as an antagonist. Only THC intoxicates. The two also part ways on chemistry, legal status and the drug test, and the human research on CBG is still very thin.
3 sections · Side by side · What the evidence settles · Common questions
The cannabis plant makes CBGA (cannabigerolic acid) first, the raw, acidic "mother acid." Heat above roughly 100 °C strips off its acid group, a step called decarboxylation, and what remains is CBG (cannabigerol), the neutral form. The two are chemically distinct and neither is intoxicating. CBG has a characterized in-vitro receptor profile; CBGA's own pharmacology is catalogue in progress.
5 sections · At a glance · From acid to neutral: what decarboxylation does · Mother acid vs mother cannabinoid · …
Two varins from the same family, with very different files. CBDV went through a proper clinical trial for seizures and failed to beat placebo. CBGV has only ever been studied in cells and mice. Both are non-intoxicating three-carbon "varin" cannabinoids.
4 sections · Side by side · What the evidence settles · Common questions · …
Shorten CBG's side chain from five carbons to three and you get CBGV. Cannabigerol (CBG) carries a pentyl tail; its "varin" relative, cannabigerovarin or CBGV, carries a propyl chain on the same core, which makes the formulas C19H28O2 for CBGV and C21H32O2 for CBG. On paper the difference is small. In the research record it is enormous: verified lab work maps how CBG acts on several receptors, while almost nothing is known about CBGV's pharmacology (catalogue in progress).
4 sections · Side by side · What the evidence establishes · Common questions · …
Leave cannabis in the light long enough and some of its CBC becomes something else. Ultraviolet light and heat close an extra ring in the molecule, and what comes out is CBL: the same formula, C₂₁H₃₀O₂, folded into a different shape. Neither one gets anyone high, and neither has been through a controlled human trial.
4 sections · Side by side · The settled facts · Common questions · …
The two start life far apart. CBN (cannabinol) forms as THC ages and oxidizes, while the plant makes CBD (cannabidiol) directly and in quantity. Neither is meaningfully intoxicating, yet their chemistry and evidence differ, and CBN carries a real drug-test risk. The sleep benefit both are sold on is not established for either.
4 sections · At a glance · What the evidence supports · Common questions · …
Leave cannabis in a jar on a sunny windowsill long enough and some of its THC becomes CBN, with oxygen, heat, light and time doing the work. The two share an origin and little else. THC is strongly intoxicating, while CBN's cannabis-like effects have been mixed in people and mostly failed to appear at all (Corroon 2021).
4 sections · At a glance · What's actually established · Common questions · …
Every hemp shopper meets the same three words on a label, and they answer a single question: what was left in the extract. Full-spectrum keeps all of the hemp plant's naturally occurring cannabinoids and terpenes, trace THC included (≤0.3% Δ⁹-THC in US hemp). Broad-spectrum keeps a range of compounds and takes the THC out. Isolate is one purified cannabinoid, alone. What sells the difference is the "entourage effect", the claim that whole-plant blends outperform isolate, and that is still an unproven hypothesis.
3 sections · At a glance · What's actually established · Common questions
THCA flower can pass as hemp in the jar and behave like marijuana in the pipe. Raw THCA doesn't intoxicate, but heat turns it into THC, which does, while CBD doesn't intoxicate at all. Once a THCA product is smoked, vaped or baked, the user is consuming THC, and a failed drug test becomes a real possibility.
4 sections · At a glance · What the evidence supports · Common questions · …
Every bit of THCA in a jar of hemp flower started life as CBGA. The plant builds CBGA first, and an enzyme, THCA synthase, reshapes it into THCA. Raw, both acids are non-intoxicating. Heat is where their paths split: decarboxylated CBGA becomes CBG, which stays that way, while THCA becomes THC, the one that gets people high.
4 sections · Side by side · The settled facts · Common questions · …
Cannabis makes THCA, an acid that doesn't get anyone high. Heat turns it into THC, which does. A flame, a vape coil or an oven strips THCA's carboxyl group off as CO₂, so a THCA product that is smoked, vaped or baked delivers THC, and whether it intoxicates comes down to whether it has been heated.
4 sections · At a glance · What's actually established · Common questions · …
CBD is the cannabinoid with a prescription medicine to its name; THCV is the one sold as "diet weed". Only CBD reliably stays non-intoxicating, because THCV's action at CB₁ changes with dose. CBD also has far more human research behind it, while THCV's appetite claim has no primary evidence in a person.
4 sections · Side by side · What the evidence settles · Common questions · …
Sellers like to file THCV beside CBG under "non-intoxicating", and only one of the two has earned the label. CBG doesn't get anyone high. THCV may, and the dose decides: in laboratory and animal work it blocks CB₁ at lower doses and can switch the same receptor on at higher ones, and nobody has established the dose at which that switch happens in people.
4 sections · At a glance · What the evidence supports · Common questions · …
One is sold to put you to sleep, the other to get you going, and the evidence treats them just as differently. CBN's sleep claim has been tested in people and came up short. THCV's energy and appetite claims have no primary evidence behind them in our registry. On intoxication, CBN is at most weakly intoxicating, while THCV's action at CB₁ shifts with the dose.
4 sections · Side by side · What the evidence settles · Common questions · …
THC (delta-9-tetrahydrocannabinol) is the main intoxicating cannabinoid, and it produces a high by activating the CB1 receptor. THCV (tetrahydrocannabivarin), its propyl analog, is marketed almost as THC's mirror image: the cannabinoid that curbs appetite instead of stoking it. Both halves of that pitch wobble. THCV's psychoactivity is dose-dependent, reported non-intoxicating at low doses and possibly intoxicating at higher ones, and its appetite effect has not been established in people; its effects in people are largely unstudied.
4 sections · At a glance · What the evidence supports · Common questions · …